Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.

Biotechnology

Health & Wellness

Amicus Therapeutics

Bradley L. Campbell

Yun Gu

Ron Skwirut

Alastair Reed

Nicholas Juenemann

Kelly Phillips

Jennifer Sullivan

Jordan Masanoff

Delayne Scelfo

Aurelien le Thiec

Sam Pierre-Louis

Pat Osullivan

Jill Weimer

Patrik Florencio

Jayne C. Gershkowitz

Jeffrey P. Castelli

Ellen S. Rosenberg

Julie Yu

David Clark

The executive team at Amicus Therapeutics has a wealth of experience in a variety of industries, including finance, accounting, compliance, human resources, and business development. They also have a wide range of educational backgrounds, including degrees in finance, accounting, political science, and biology.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Amicus Therapeutics

Leadership Team

Board of Directors